Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy

D D'Andrea, F Soria, M Abufaraj, K Gust, B Foerster, MD Vartolomei, S Kimura, A Mari, A Briganti, M Remzi, CK Seitz, R Mathieu, PI Karakiewicz, SF Shariat

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To evaluate the predictive and prognostic role as well as the clinical impact on decision-making of serum cholinesterase (ChoE) levels in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer. Materials and methods: We conducted a retrospective analysis of our multi institutional database. Preoperative ChoE was evaluated as continuous and dichotomized variable using a visual assessment of the functional form of the association of ChoE with biochemical recurrence (BCR)-free survival. We assessed its association with perioperative clinicopathologic characteristics and outcomes. Multivariable models established its independent prognostic value for BCR. Cox proportional hazard coefficients were used to build nomograms for the prediction of early and late BCR. Decision curve analysis was used to assess the clinical impact on decision making of preoperative ChoE. Results: In all, 6,041 patients were available for the analysis. Decreased ChoE was associated with higher biopsy Gleason score, preoperative PSA levels, pathologic Gleason score, pathological stage, lymph node metastasis, positive surgical margin, and lymphovascular invasion at radical prostatectomy (all P <0.01). Preoperative ChoE ≤ 6.52 U/ml was associated with higher probability of BCR (HR 1.72, 95% CI 1.48–1.99, P <0.001). Preoperative and postoperative multivariable models that adjusted for the effects of established clinicopathologic features confirmed its independent association with BCR. In decision curve analysis inclusion of preoperative ChoE did not improve the net benefit of preoperative and postoperative models for the prediction of BCR. Conclusions: Despite independent association with clinicopathologic features and BCR, preoperative serum ChoE has no impact on clinical decision making. Future studies should investigate the possible relationship between ChoE activity and neoplastic cell transformation with a rational for targeting. © 2018
Original languageEnglish
Pages (from-to)528.e7-528.e13
JournalUrologic Oncology: Seminars and Original Investigations
Volume36
Issue number12
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy'. Together they form a unique fingerprint.

Cite this